Tripotassium dicitrato bismuthate

Active ingredient description

Under the effect of gastric acid, a precipitate is formed from tripotassium dicitrato bismuthate, which adheres primarily to the ulcerated area and inhibits the activity of pepsin. Tripotassium dicitrato bismuthate contributes to the healing of a high percentage of gastric and duodenal ulcers.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
A02BX05
Bismuth subcitrate
A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
Discover more medicines within A02BX05

Medicines

Tripotassium dicitrato bismuthate is the active ingredient of these drugs:

Drug
Countries
DENOL

South Africa

GASTRODENOL

Spain

HERICOBA

Singapore

ULCAMED

Austria Lithuania

Tripotassium dicitrato bismuthate is also found within below combination drugs:

PYLERA

Structural formula

Graphic representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

HS813P8QPX - BISMUTH SUBCITRATE

Next: Usage